Compare Johnson & Johnson (JNJ) vs Invesco Preferred ETF (PGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Invesco Preferred ETF — how do they compare? Johnson & Johnson trades at $260.67 (market cap $618.09B), while Invesco Preferred ETF trades at $10.03 (market cap $3.60B). The key difference: Johnson & Johnson is far larger — about 171.7× Invesco Preferred ETF's market cap, and Johnson & Johnson pays a 2.09% dividend while Invesco Preferred ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Invesco Preferred ETF for 95 Days on average.
| JNJ | PGX | |
|---|---|---|
Market Cap | $618.09B | $3.60B |
Volume | 6,050,983 | 5,986,026 |
Sector | Health | — |
52-Week High | $278.43 | $11.61 |
52-Week Low | $186.00 | $9.97 |
Typical Hold Time | 129 Days | 95 Days |
Enterprise Value | $646.37B | — |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.
PGX trades at $10.01, up 0.4% with bearish technical indicators showing 18 sell signals versus 3 buy signals. The stock faces resistance at $10 with RSI at neutral levels. Recent dividends of $0.06 were declared for July and September 2026, providing income potential amid technical weakness.
The outlook remains cautious with strong bearish momentum in moving averages. Investment opportunity lies in dividend yield while risks include technical breakdown below $10 support. Fundamental analysis is limited without current financial ratios, requiring updated SEC filings for proper valuation assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →
